Lantern Pharma files 8-K disclosure with exhibit materials
Lantern Pharma Inc. submitted an 8-K filing with SEC containing exhibit materials. The filing lacks specific material information from the provided text excerpt.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day